Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

May 12, 2020; 94 (19) Special Editorial

Neurologic complications of coronavirus infections

View ORCID ProfileAvindra Nath
First published March 30, 2020, DOI: https://doi.org/10.1212/WNL.0000000000009455
Avindra Nath
From the Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Avindra Nath
Full PDF
Citation
Neurologic complications of coronavirus infections
Avindra Nath
Neurology May 2020, 94 (19) 809-810; DOI: 10.1212/WNL.0000000000009455

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
19908

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

In 1896, Sir William Osler1 said, “Humanity has but three great enemies: fever, famine, and war; of these by far the greatest, by far the most terrible, is fever.” This rings true even today.

The newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has stricken fear and panic among the public, health care workers, patients, politicians, and financial markets. Fear strikes the minds of the unprepared. So we must ask ourselves why have we been caught by surprise? In the recent past, there have been many major epidemics. This includes Ebola, Zika, dengue, chikungunya, acute flaccid myelitis, and H1N1 influenza, to name a few. But SARS-CoV2 is different. It struck home! And so very rapidly. It emerged in the region of Wuhan in China around December last year, and by March, every state in the United States and over a hundred countries have reported cases of the infection with deaths in all the adult age groups. The predictions are dire. The entire health care system could potentially be overwhelmed and could crumble. Signs of that are already evident in New York and Washington state. Grocery stores have empty shelves, pharmacies are running out of critical medications, and there is scarcity of personal protection equipment and ventilators.

The major clinical manifestations of the SARS-CoV2 infection are due to pulmonary complications. Although most have mild symptoms, such as fever, headache, cough, dyspnea, myalgia, and anosmia, some develop acute respiratory distress syndrome about a week into the illness, which can result in death.2 Rhabdomyolysis can be a late complication of the infection.3 The mortality rate is about 3%–4%. Terminally, patients go into coma, which is thought to be due to hypoxia or multiorgan failure. But many unanswered questions remain. Could the headache be symbolic of viral meningitis? There is a report of detection of the virus in the CSF of 1 patient (encephalitis.info/blog/coronavirus). Does anosmia suggest involvement of the olfactory bulbs? In mouse models of coronavirus encephalitis, the virus can enter the brain transneuronally through the olfactory pathways.4 Hence, this relatively innocuous symptom could be indicative of a potentially more serious complication. Can the respiratory syndrome be due to brainstem involvement? Brain imaging and pathologic evaluation of the brain are necessary to understand the full impact of the virus. The elderly and immunocompromised patients are particularly vulnerable. Many have underlying neurologic comorbidities. Hypertension and diabetes seem to stand out as the most common comorbidities in patients with more severe manifestations of the infection. An interesting hypothesis has emerged around the use of angiotensin-converting enzyme (ACE) inhibitors to treat hypertension and diabetes to explain this phenomenon. ACE2 is the receptor for SARS-CoV2.5 The use of ACE inhibitors leads to increased expression of ACE2, making the cells more vulnerable to infection with the virus. Clinical studies are underway to test this hypothesis. ACE2 can be found on endothelial cells in the brain and can be induced in neurons, raising the possibility that strokes associated with SARS-CoV2 might be directly related to the infection, and encephalitis could be a potential complication.

There are several human coronaviruses (HCoVs). Most cause mild respiratory symptoms and resolve. However, in recent years, new coronaviruses have jumped species and infected humans with devastating consequences. Several acute neurologic syndromes have been associated with coronaviruses (table). Severe acute respiratory syndrome coronavirus 1 has been detected in the CSF of a patient with encephalitis and acute respiratory distress syndrome.6 Middle East respiratory syndrome coronavirus can cause a severe acute disseminated encephalomyelitis and a vasculopathy.7 A postinfectious brainstem encephalitis and Guillain-Barré syndrome have also been described.8 HCoV-OC43 can also cause an acute disseminated encephalomyelitis with lesions scattered throughout the brain, cerebellum, and spinal cord.9 Immunocompromised individuals are particularly vulnerable. A fatal encephalitis can occur in immunocompromised patients with HCoV-OV43. In these patients, infection of neurons has been demonstrated at autopsy.10 A similar concern has been raised with SARS-CoV2. Many patients with autoimmune syndromes such as multiple sclerosis, myasthenia gravis, neuromyelitis optica, or sarcoidosis are on a wide variety of immunosuppressive therapies. Drugs that cause systemic immune suppression wound be of concern. It might be prudent for such patients to take extra precautions to prevent exposure to the virus and to reevaluate the dosages of the medications. However, it may not be advisable to take them off treatment because the underlying illness will surely re-emerge, causing serve manifestations in many. With restrictions on travel being imposed and all elective patient appointments being canceled, there is an urgent cry for teleneurology as a substitute for face-to-face interactions with patients. However, to make this work, we need to develop a centralized system to license physicians in the entire country and not in each state individually.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table

Acute neurologic complications of coronavirus infections

Seropositivity for coronaviruses has been reported in a variety of neurologic disorders, which include encephalitis,11 optic neuritis,12 multiple sclerosis,13 and Parkinson disease.14 Virus has also been isolated from the CSF and brain of patients with multiple sclerosis.15 Viruses implicated include HCoV-229E, HCoV-293, and HCoV-OC43. But the significance of these findings is not clear because these viruses are very prevalent and their causative role in these diseases has not been established.

In the past century, we have made tremendous progress in the prevention, diagnosis, and treatment of diseases. We can dissolve clots in the carotids, we can fix mutated genes before they can cause harm, and we can image the brain and its networks with exquisite precision, yet we have been brought down to our knees by the tiniest of organisms, about 60 nm in size. We need to retool and rethink how we train physicians in the practice of neurology and physician scientists in the academic neurology and how we prioritize drug development for neurologic diseases, and we need to enable academia and pharma to develop treatments not based on profits but rather on costs to humanity. Although we all recognize the hundreds of viruses that can cause encephalitis and result in devastation to large populations, we have no treatment for any of these organisms except for herpes encephalitis. It is time for us to recognize that we are facing a crisis in neurology.16 The time to take action is now.

Study funding

This work is supported by the intramural funds from the National Institute of Neurological Disorders and Stroke at the NIH, ZIA NS003130.

Disclosure

The author reports no disclosures. Go to Neurology.org/N for full disclosures.

Footnotes

  • Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

  • COVID-19 Resources: NPub.org/COVID19

  • Received March 23, 2020.
  • Accepted in final form March 24, 2020.
  • © 2020 American Academy of Neurology

References

  1. 1.↵
    1. Osler W
    . The study of the fevers of the South. JAMA 1896;26:999–1004.
    OpenUrl
  2. 2.↵
    1. Zhou F,
    2. Yu T,
    3. Du R, et al
    . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054–1062.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Jin M,
    2. Tong Q
    . Rhabdomyolysis as potential late complication associated with 2019 novel coronavirus disease. Emerg Infect Dis Epub 2020 March 20.
  4. 4.↵
    1. Dubé M,
    2. Le Coupanec A,
    3. Wong AHM,
    4. Rini JM,
    5. Desforges M,
    6. Talbot PJ
    . Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43. J Virol 2018;92:e00404–e00418.
    OpenUrl
  5. 5.↵
    1. Yan R,
    2. Zhang Y,
    3. Li Y,
    4. Xia L,
    5. Guo Y,
    6. Zhou Q
    . Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2. Science 2020;367:1444–1448.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Hung EC,
    2. Chim SS,
    3. Chan PK, et al
    . Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. Clin Chem 2003;49:2108–2109.
    OpenUrlFREE Full Text
  7. 7.↵
    1. Arabi YM,
    2. Harthi A,
    3. Hussein J, et al
    . Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV). Infection 2015;43:495–501.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Kim JE,
    2. Heo JH,
    3. Kim HO, et al
    . Neurological complications during treatment of Middle East respiratory syndrome. J Clin Neurol 2017;13:227–233.
    OpenUrl
  9. 9.↵
    1. Yeh EA,
    2. Collins A,
    3. Cohen ME,
    4. Duffner PK,
    5. Faden H
    . Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis. Pediatrics 2004;113:e73–e76.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Morfopoulou S,
    2. Brown JR,
    3. Davies EG, et al
    . Human coronavirus OC43 associated with fatal encephalitis. N Engl J Med 2016;375:497–498.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Li Y,
    2. Li H,
    3. Fan R, et al
    . Coronavirus Infections in the central nervous system and respiratory tract show distinct features in hospitalized children. Intervirology 2016;59:163–169.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Dessau RB,
    2. Lisby G,
    3. Frederiksen JL
    . Coronaviruses in spinal fluid of patients with acute monosymptomatic optic neuritis. Acta Neurol Scand 1999;100:88–91.
    OpenUrlPubMed
  13. 13.↵
    1. Salmi A,
    2. Ziola B,
    3. Hovi T,
    4. Reunanen M
    . Antibodies to coronaviruses OC43 and 229E in multiple sclerosis patients. Neurology 1982;32:292–295.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Fazzini E,
    2. Fleming J,
    3. Fahn S
    . Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease. Mov Disord 1992;7:153–158.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Burks JS,
    2. Devald BL,
    3. Janovsky LD,
    4. Gerdes JC
    . Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients. Science 1980;209:933–934.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Nath A
    . Neuroinfectious diseases: a crisis in neurology and a call for action. JAMA Neurol 2015;72:143–144.
    OpenUrl

Letters: Rapid online correspondence

  • Author response: Neurologic complications of coronavirus infections
    • Avindra Nath, Neurologist, National Institute of Neurological Disorders and Stroke, National Institutes of Heath
    Submitted June 22, 2020
  • Reader response: Neurologic complications of coronavirus infections
    • Lucrecia N. Bandeo, Neurologist, Hospital Británico de Buenos Aires
    • Pablo Bonardo, Neurologist, Hospital Británico de Buenos Aires
    • Manuel M. Fernandez Pardal, Neurologist, Hospital Británico de Buenos Aires
    • Ricardo C. Reisin, Neurologist, Hospital Británico de Buenos Aires
    Submitted June 09, 2020
  • Reader response: Neurologic complications of coronavirus infections
    • Peter S. Steyger, PhD, Translational Hearing Center, Creighton University (Omaha, NE)
    • Sharon G. Kujawa, MS PhD, Massachusetts Eye and Ear (Boston)
    • Leslie A. Shinobu, MD, PhD, (Boston)
    Submitted April 18, 2020
  • Reader response: Neurologic complications of coronavirus infections
    • Pedro Jesus Serrano-Castro, Neurologist, Regional Universitary Hospital of Malaga, Biomedical Research Institute of Malaga (IBIMA)
    Submitted April 17, 2020
  • Reader response: Neurologic complications of coronavirus infections
    • Calixto Machado, Neurologist, Insttitute of Neurology and Neurosurgery (Havana, Cuba)
    Submitted April 13, 2020
  • Reader response: Neurologic complications of coronavirus infections
    • Thirugnanam Umapathi, Neurologist, National Neuroscience Institute (Singapore, Singapore)
    Submitted April 03, 2020
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Study funding
    • Disclosure
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis

Dr. Robert Pitceathly and Dr. William Macken

► Watch

Related Articles

  • No related articles found.

Topics Discussed

  • Viral infections
  • Risk factors in epidemiology

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Views & Reviews
    Presentations and mechanisms of CNS disorders related to COVID-19
    Marta Bodro, Yaroslau Compta, Raquel Sánchez-Valle et al.
    Neurology: Neuroimmunology & Neuroinflammation, December 11, 2020
  • Review
    Potential Neurologic Manifestations of COVID-19
    Anna S. Nordvig, Kathryn T. Fong, Joshua Z. Willey et al.
    Neurology: Clinical Practice, June 30, 2020
  • Article
    Neurologic and neuroimaging findings in patients with COVID-19
    A retrospective multicenter study
    Stéphane Kremer, François Lersy, Mathieu Anheim et al.
    Neurology, July 17, 2020
  • Review
    Neurology and the COVID-19 Pandemic
    Gathering Data for an Informed Response
    Brigit High, Alison M. Hixon, Kenneth L. Tyler et al.
    Neurology: Clinical Practice, July 13, 2020
Neurology: 100 (12)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise